Your browser doesn't support javascript.
loading
Lot verification practices in Ontario clinical chemistry laboratories - Results of a patterns-of-practice survey.
Rutledge, Angela C; Johnston, Anna; Booth, Ronald A; Veljkovic, Kika; Bailey, Dana; Vandenberghe, Hilde; Waite, Gayle; Allen, Lynn C; Don-Wauchope, Andrew; Chan, Pak Cheung; Stemp, Julia; Edmond, Pamela; Leung, Victor; Aslan, Berna.
Afiliação
  • Rutledge AC; Institute for Quality Management in Healthcare (IQMH) Endocrinology and Immunology Scientific Committee, Toronto, Ontario, Canada.
  • Johnston A; Department of Pathology and Laboratory Medicine, London Health Sciences Centre and St. Joseph's Health Care London, London, Ontario, Canada.
  • Booth RA; Institute for Quality Management in Healthcare (IQMH) Endocrinology and Immunology Scientific Committee, Toronto, Ontario, Canada.
  • Veljkovic K; IQMH, Toronto, Ontario, Canada.
  • Bailey D; Institute for Quality Management in Healthcare (IQMH) Endocrinology and Immunology Scientific Committee, Toronto, Ontario, Canada.
  • Vandenberghe H; Division of Biochemistry, The Ottawa Hospital and Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Waite G; Institute for Quality Management in Healthcare (IQMH) Endocrinology and Immunology Scientific Committee, Toronto, Ontario, Canada.
  • Allen LC; LifeLabs, Toronto, Ontario, Canada.
  • Don-Wauchope A; Institute for Quality Management in Healthcare (IQMH) Endocrinology and Immunology Scientific Committee, Toronto, Ontario, Canada.
  • Chan PC; Dynacare Medical Laboratories, Brampton, Ontario, Canada.
  • Stemp J; IQMH Chemistry Scientific Committee, Toronto, Ontario, Canada.
  • Edmond P; Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Leung V; Dynacare Medical Laboratories, Brampton, Ontario, Canada.
  • Aslan B; IQMH Chemistry Scientific Committee, Toronto, Ontario, Canada.
Pract Lab Med ; 32: e00300, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36035320
Objectives: Verifying new reagent or calibrator lots is crucial for maintaining consistent test performance. The Institute for Quality Management in Healthcare (IQMH) conducted a patterns-of-practice survey and follow-up case study to collect information on lot verification practices in Ontario. Methods: The survey had 17 multiple-choice questions and was distributed to 183 licensed laboratories. Participants provided information on materials used and approval/rejection criteria for their lot verification procedures for eight classes of testing systems. The case study provided a set of lot comparison data and was distributed to 132 laboratories. Responses were reviewed by IQMH scientific committees. Results: Of the 175 laboratories that responded regarding reagent lot verifications, 74% verified all tests, 11% some, and 15% none. Of the 171 laboratories that responded regarding calibrator lot verifications, 39% verified all calibrators, 4% some, and 57% none. Reasons for not performing verifications ranged from difficulty performing parallel testing to high reagent cost. For automated chemistry assays and immunoassays, 23% of laboratories did not include patient-derived materials in reagent lot verifications and 42% included five to six patient materials; 58% of laboratories did not include patient-derived materials in calibrator lot verifications and 23% included five to six patient materials. Different combinations of test-specific rules were used for acceptance criteria. For a failed lot, 98% of laboratories would investigate further and take corrective actions. Forty-three percent of laboratories would accept the new reagent lot in the case study. Conclusion: Responses to the survey and case study demonstrated variability in lot verification practices among laboratories.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article